flecainide / Generic mfg. 
Welcome,         Profile    Billing    Logout  

29 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
flecainide / Generic mfg.
2012-001898-90: Effects of vernakalant and flecainide on atrial contractility in patients with AF De effecten van vernakalant en flecaïnide op de knijpkracht van de boezems bij patiënten met boezemfibrilleren

Ongoing
4
50
Europe
Brinavess, Tambocor, SUB30707, Concentrate for solution for infusion, Solution for injection, Brinavess, Tambocor
Maastricht University Medical Center, Maastricht University Medical Center
Patients with paroxysmal or persistent atrial fibrillation (AF) reporting at the first heart aid. Patiënten met paroxysmaal of persisterend atriumfibrilleren (AF) die zich melden op de eerste hart hulp., Patients with atrial fibrillation (heart rhythm disorder) reporting at the first heart aid. Patiënten met boezemfibrilleren (hartritmestoornis) die zich melden op de eerste hart hulp., Diseases [C] - Cardiovascular Diseases [C14]
 
 
2016-003325-41: PREemptive Pharmacogenomic testing for Preventing Adverse drug REactions (PREPARE)

Ongoing
4
450
Europe
Syrup, Tablet, Capsule, hard, Powder for injection, Capsule, Solution for injection, Concentrate for solution for infusion, Powder for solution for infusion, Codeine, Acenocoumarol, Amitriptyline, Aripiprazole, Atomoxetine, Atorvastatine, Azathioprine, Capecitabine, Carbamazepine, Citalopram, Clomipramine, Clopidogrel, Clozapine, Efavirenz, Escitalopram, Flecainide, Flucloxacillin, Fluorouracil, Haloperidol, Irinotecan, Mercaptopurine, Metoprolol, Oxycodone, Paroxetine, Phenprocoumon, Phenytoin, ORAP 1 mg Tabletten, Propafenone, Sertraline, Simvastatin, Tacrolimus, Tamoxifen, Tegafur, Tioguanine, Tramadol, Venlafaxine, Voriconazole, Zuclopenthixol, Ethinylestradiol, ORAP 4 mg Tabletten
Leiden University Medical Center, Leiden University Medical Center
Adverse drug reactions, Side-effects, Not possible to specify
 
 
2018-001518-13: Elimination of ventricular premature beats and ventricular tachycardia with catheter ablation versus optimal anti-arrhythmic drug treatment Eliminatie van premature ventriculaire complexen met catheter ablatie versus optimale medicamenteuze behandeling met anti-arritmica.

Not yet recruiting
4
180
Europe
Sotalol, Verapamil, Flecainide, Tablet
Maatschap Cardiologie Zwolle, Isala Zwolle
Premature ventricular beats, ventricular ectopy, ventricle tachycardia Premature ventriculaire complexen, ventriculaire extrasystolen, ventriculaire tachycardie, Premature cardiac beat Ventriculaire extrasystole (VES), Diseases [C] - Cardiovascular Diseases [C14]
 
 
SELECTCARFAP, NCT03005366 / 2014-003641-95: Predictive Factors to Effectively Terminate Paroxysmal Atrial Fibrillation by Blocking Atrial Selective Ionic Currents

Completed
4
50
Europe
Vernakalant, BRINAVESS, Flecainide, APOCARD
David Filgueiras-Rama, Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Paroxysmal Atrial Fibrillation
06/23
08/23
FLIP-AF, NCT06142604: Single Dose Flecainide for Early Sinus Rhythm Conversion of Perioperative Atrial Fibrillation After Noncardiac Surgery

Not yet recruiting
4
20
NA
Flecainide
Population Health Research Institute
Atrial Fibrillation, Surgery
06/25
12/25
NCT02347111: Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

Recruiting
4
162
US
Flecainide, Sotalol
University of Illinois at Chicago, Medtronic
Atrial Fibrillation
06/25
06/25
2015-005743-14: Fetal atrial Flutter & Supraventricular Tachycardia (FAST) Therapy Trial

Ongoing
3
600
Europe
Flecainide acetate, sotalol, Digoxin, Tablet, Injection, flecainide acetate, SOTALOL, Digoxin
St Georges University Hospital NHS Foundation Trust
Fetal atrial flutter without hydrops, supraventricular tachycardia without hydrops and supraventricular tachycardia with hydrops, fetal heart rhythm abnormalities, Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
 
 
2021-004865-11: Not applicable

Ongoing
3
110
Europe
FLECARDIA, Ranexa, Solution for injection/infusion, Prolonged-release tablet, FLECARDIA, Ranexa
Win Medica Pharmaceuticals S.A., Win Medica Pharmaceuticals S.A.
Restoration of sinus rhythm in patients with recent AF onset Αποκατάσταση του φλεβοκομβικού ρυθμού σε ασθενείς με ΚΜ προσφάτου ενάρξεως, Restoration of sinus rhythm in patients with recent AF onset Αποκατάσταση του φλεβοκομβικού ρυθμού σε ασθενείς με ΚΜ προσφάτου ενάρξεως, Diseases [C] - Cardiovascular Diseases [C14]
 
 
2021-006614-37: First-line catheter ablation for early treatment of Persistent (ongoing unless cardioverted) Atrial Fibrillation (AF) – a randomized study comparing isolation of pulmonary veins triggering AF using a Cryoballoon versus antiarrhythmic medication. Kryoablation som förstahandsval för tidig behandling av persisterande (fortgående såvida inte elektrisk eller medicinsk konvertering ges) förmaksflimmer - en randomiserad studie som jämför lungvensisolering med rytmstabiliserande läkemedel.

Ongoing
3
220
Europe
Tablet, tambocor, multaq, rytmonorm, sotalol
Carina Blomström Lundqvist, Swedish Research Council, Familjen Erling-Perssons Stiftelse, Swedish Heart and Lung Foundation
Persistent symptomatic atrial fibrillation Persisterande symptomatiskt förmaksflimmer, Irregular heart rhythm proved to be persistent symptomatic atrial fibrillation (chaotic rhythm in the hearts atria) that requires electrical or medical cardioversion to normal rhythm. Oregelbunden hjärtrytm som beror på ihållande förmaksflimmer som kräver medicinsk eller elektrisk konvertering för omslag till sinus rytm., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
 
 
NCT02624765: Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT)

Completed
3
105
Europe, Canada, US, RoW
Digoxin (monotherapy), Sotalol (monotherapy), Flecainide (monotherapy), Digoxin (dual therapy), Sotalol (dual therapy), Flecainide (dual therapy)
Edgar Jaeggi, Canadian Institutes of Health Research (CIHR)
Fetal Atrial Flutter Without Hydrops, Fetal Supraventricular Tachycardia Without Hydrops, Fetal Supraventricular Tachycardia With Hydrops
03/24
03/24
RESTORE-1, NCT05039359: Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation

Terminated
3
54
Europe, US, RoW
FlecIH-103
InCarda Therapeutics, Inc.
Paroxysmal Atrial Fibrillation
05/23
05/23
AFLOAT, NCT05213104: Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia

Active, not recruiting
3
186
Europe
Flecainide, Flecainide Acetate 150 MG
Assistance Publique - Hôpitaux de Paris, Fonds de Dotation ACTION
Patent Foramen Ovale, Atrial Arrhythmia, Cryptogenic Stroke
02/24
07/26
FLECA-ED, NCT05549752: Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia

Recruiting
3
200
Europe
Flecainide Injectable Solution, Amiodarone Injectable Solution
Hippocration General Hospital, Win Medica, Pharmassist Ltd
Atrial Fibrillation Paroxysmal, Coronary Artery Disease Without Residual Ischemia
10/24
11/24
FLECAPRO, NCT05631730: Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse

Recruiting
3
50
Europe
Flecainide, C01B C04, Metoprolol, C07A B02
Oslo University Hospital, The Research Council of Norway, University of Oslo
Mitral Valve Prolapse, Ventricular Arrhythmias and Cardiac Arrest
02/26
02/26
NCT05939076: First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation

Not yet recruiting
3
220
Europe
Pulmonary vein isolation, dronedarone - Multaq™ OR flecainide - Tambocor™ OR propafenone - Rytmonorm™ OR sotalol - Sotacor™
Region Örebro County, The Swedish Research Council, Erling-Persson Stiftelse, Swedish Heart Lung Foundation, Uppsala University
Atrial Fibrillation, Persistent
12/27
12/28
EAST-STROKE, NCT05293080: Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE

Not yet recruiting
3
1746
NA
Medical or interventional therapy for rhythm control in atrial fibrillation (antiarrhythmic drugs, ablation, electric cardio version), Usual care for atrial fibrillation
Universitätsklinikum Hamburg-Eppendorf, University Heart & Vascular Center Hamburg, Department of Cardiology, Department of Neurology, Royal Melbourne Hospital, Melbourne Heart Centre, Royal Melbourne Hospital, Hotchkiss Brain Institute, University of Calgary, Department of Neurology and Neurosurgery, Brain Center, University Medical Center Utrecht, UMC Utrecht, Edinburgh Clinical Trials Unit, Cerebrovascular Research Group, Centre for Clinical Brain Sciences, University of Edinburgh, Department of Cardiovascular Sciences, University of Leicester British Heart Foundation Cardiovascular Research Centre, Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, CTC-NORTH, Stroke Alliance for Europe (SAFE), Kompetenznetz Vorhofflimmern e.V. (AFNET)
Acute Ischemic Stroke, Atrial Fibrillation
09/28
03/29
ACTRN12608000338369: Flecainide in amyotrophic lateral sclerosis - a potential neuroprotective strategy.

Recruiting
2
100
 
South Eastern Sydney Illawarra Area Health Service, A/Prof. Matthew Kiernan
Motor neuron disease, Amyotrophic lateral sclerosis
 
 
2011-001287-22: Clinical trial of Flecainide for Catecholaminergic Ventricular Tachycardia Studio clinico sulla somministrazione di Flecainide nella tachicardia ventricolare catecolaminergica

Ongoing
2
10
Europe
Tablet
FONDAZIONE SALVATORE MAUGERI - CLINICA DEL LAVORO E DELLA RIABILITAZIONE, Vanderbilt University
Patients with CPVT and ICD Pazienti con CPVT e ICD, Patients with catecholaminergic ventricular tachycardia and implantable defibrillator Pazienti con tachicardia ventricolare catecolaminergica e defibrillatore impiantabile, Diseases [C] - Cardiovascular Diseases [C14]
 
 
NCT06205550: N-of-1 in ATS and MEPPC

Not yet recruiting
2
10
NA
Flecainide, Flecainide + beta-blocker
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Andersen Tawil Syndrome, Multifocal Ectopic Purkinje-related Premature Contractions
04/25
05/25
AI4Cardio, NCT06376552: Artificial Intelligence for the Prioritization of Genetic Background in Brugada Syndrome

Completed
N/A
200
Europe
IRCCS San Raffaele
Brugada Syndrome
06/22
06/22
PROGRESSIVE-AF, NCT05514860: The Impact of "First-Line" Rhythm Therapy on AF Progression

Active, not recruiting
N/A
303
Canada
Cryoballoon-based PVI, Anti-Arrhythmic Drug Therapy
University of British Columbia, Ottawa Heart Institute Research Corporation, Medtronic
Atrial Fibrillation
09/22
11/22
EARLY-AF, NCT02825979: Early Aggressive Invasive Intervention for Atrial Fibrillation

Active, not recruiting
N/A
303
Canada
Cryoballoon-based PVI, Anti-Arrhythmic Drug Therapy, sotalol, flecainide, propafenone, dronedarone
Jason Andrade, Ottawa Heart Institute Research Corporation, Medtronic, Baylis Medical Company
Atrial Fibrillation
09/22
11/22
ECTOPIA, NCT03845010: Elimination of VPB With Ablation Versus Anti-arrhythmic Drug Treatment

Completed
N/A
22
Europe
Sotalol, Flecainide and verapamil, Catheter ablation
Maatschap Cardiologie Zwolle
Ventricular Premature Beats
01/23
01/23
AVANT GUARD, NCT06096337: Pulsed Field Ablation (PFA) Versus Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation

Recruiting
N/A
387
Europe, Canada, US, RoW
FARAPULSE™ Pulsed Field Ablation (PFA) System, Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, and Dofetilide
Boston Scientific Corporation
Persistent Atrial Fibrillation
12/25
12/27
NCT04837261: Shortening Duration of Antiarrhythmic Medication for SVT in Infants

Recruiting
N/A
70
Europe
Propranolol, Flecainide, Amiodarone
Tampere University Hospital, Helsinki University Central Hospital, Kuopio University Hospital, Oulu University Hospital, Turku University Hospital
Supraventricular Tachycardia
01/24
01/24
EDearly AF, NCT06322017: Prospective Multicenter Randomized and Controlled Study Evaluating the Benefit of Early Pulmonary Vein Isolation Compared to Usual Treatment in Patients Aged Over 75 Years and Presenting With Atrial Fibrillation

Recruiting
N/A
294
Europe
Rhythm control by Pulmonary Vein Isolation (PVI) procedure, Conventional care by antiarrhythmic drugs (flecainide, sotalol, amiodarone) or bradycardic drugs (all betablocker or calcium channel blocker therapy, digoxin)
Nantes University Hospital
Atrial Fibrillation
04/28
04/28
FALCON, NCT05790707: EfFect of Ablation of Persistent AtriaL Fibrillation on COgNitive Function in Individuals With Mild Cognitive Impairment

Recruiting
N/A
120
Europe
Atrial fibrillation ablation + antiarrhythmic drugs, Antiarrhythmic drug
Poitiers University Hospital
Mild Cognitive Impairment, Persistent Atrial Fibrillation
02/25
02/25
NCT05084495: The Use of Flecainide for Treatment of Atrial Fibrillation

Recruiting
N/A
100
Europe
Global peak atrial longitudinal strain and ECG
Lund University
Atrial Fibrillation
10/25
10/25
ACTRN12621000896875: WITHDRAWal of heart failure directed therapies in recovered Atrial Fibrillation mediated cardiomyopathy- the WITHDRAW-AF study

Recruiting
N/A
60
 
Alfred Hospital, Alfred Hospital
atrial fibrillation, heart failure
 
 

Download Options